Tag: Sanofi-Aventis
Duxipent increasingly lucrative: Sanofi achieves success in COPD treatment
Duxipent more and more lucrative Sanofi achieves success in COPD treatment 03/23/2023, 5:13 p.m The remedy Dupixent shows success in seven diseases. In the most recent study, all goals in…
Booster with a strong immune response: Sanofi/GSK want to get back into the corona vaccination race
Booster with strong immune response Sanofi/GSK want to get back into the corona vaccination race 6/13/2022, 5:34 p.m The EU has ordered – but the French-British cooperation between Sanofi and…
Optimism on Wall Street: Investors are back to stocks
Tuesday, August 03, 2021 Optimism on Wall Street Investors are back to stocks While the start of the week ended with a breather, buyers are coming back to the market…
British vaccination cheapest: Sanofi vaccine should cost less than ten euros
While a Chinese manufacturer is charging more than 100 euros and an American competitor over 30 dollars per dose for their corona vaccines currently being developed, European pharmaceutical companies only…